Population In Vitro-In Vivo Correlation Model for Pramipexole Slow-Release Oral Formulations

2009 ◽  
Vol 27 (2) ◽  
pp. 340-349 ◽  
Author(s):  
Elena Soto ◽  
Sebastian Haertter ◽  
Michael Koenen-Bergmann ◽  
Alexander Staab ◽  
Iñaki F. Trocóniz
2019 ◽  
Vol 64 (No. 7) ◽  
pp. 294-301
Author(s):  
S Gonzalez-Munoz ◽  
J Sanchez ◽  
S Lopez-Aguirre ◽  
J Vicente ◽  
J Pinos-Rodriguez

One in vitro assay and one in vivo trial with ruminally cannulated Holstein steers were conducted to evaluate the effects of a dietary substitution of soybean meal by a urea and slow-release urea source of fermentation and degradation of diets for cattle. The experimental diets consisted of the total mixed rations defined as the control with soybean meal (SBM), U (urea), SRU (slow-release urea), and SRU+U+AA (0.42% + 0.42% + 1% amino acids methionine and lysine). The dietary substitution of SBM by U or SRU reduced (P < 0.05) the total gas production (V), microbial mass and degradation at 72 h incubation under the in vitro conditions, as well as the degradation rate (c) and the total volatile fatty acids (VFA) in the rumen of the steers; however, when the dietary substitution of SBM was by U+SRU+AA, those values did not decrease. In the steers, the dietary substitution of SBM by U and SRU reduced the ruminal degradation rate and the total VFA, and increased the ammonia N, but when SBM was substituted by U+SRU+AA in the diets, these changes were not observed. No advantage of SRU over U was found. The dietary substitution of SBM by U, SRU, U+SRU+AA did not modify the molar proportion of the VFA in the rumen nor were there changes in the nutrient digestion or excretion. Both the in vitro assay and the in vivo trial indicated that replacing SBM with U or SRU increases the ruminal ammonia N concentrations and reduces the degradation rate in the rumen, although those undesirable findings were not found when the SBM was replaced by U+SRU+AA. Therefore, it is feasible to replace the SBM with a combination of urea, slow-release urea, lysine and methionine in the diet for the ruminants.


2016 ◽  
Vol 33 (7) ◽  
pp. 1782-1794 ◽  
Author(s):  
Ahmad Y. Abuhelwa ◽  
Stuart Mudge ◽  
David Hayes ◽  
Richard N. Upton ◽  
David J. R. Foster

1992 ◽  
Vol 152 (2) ◽  
pp. 422-429 ◽  
Author(s):  
Elizabeth C. Downs ◽  
Nancy E. Robertson ◽  
Terry L. Riss ◽  
Marian L. Plunkett

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Carol L. Berkower ◽  
Nicole M. Johnson ◽  
Stephen B. Longdo ◽  
Shenika O. McGusty-Robinson ◽  
Samantha L. Semenkow ◽  
...  

Following initial infection, herpesviruses retreat into a permanent latent state with periodic reactivation resulting in an enhanced likelihood of transmission and clinical disease. The nucleoside analogue acyclovir reduces clinical symptoms of the three human alpha herpesviruses, HSV-1, HSV-2, and VZV. Long-term administration of acyclovir (ACV) can reduce the frequency and severity of reactivation, but its low bioavailability and short half-life require a daily drug regimen. Our lab is working to develop a subcutaneous delivery system to provide long-lasting, sustained release of ACV. Previously, we demonstrated that an implantable silicone (MED-4050) device, impregnated with ACV protected against HSV-1 bothin vitroandin vivo. Here, we extend ourin vitroobservations to include protection against both HSV-2 and VZV. We also demonstrate protection against HSV-2in vitrousing MED-4750, a silicone polymer designed for long-term use in humans. When release of ACV from MED-4750 is quantitated on a daily basis, an initial burst of 5 days is observed, followed by a long period of slow release with near-zero-order kinetics, with an average daily release of 1.3923 ± 0.5908 μg ACV over days 20–60. Development of a slow-release implant has the potential to significantly impact the treatment of human alpha herpesvirus infections.


2007 ◽  
Vol 392 (3) ◽  
pp. 305-314 ◽  
Author(s):  
I. Wilcke ◽  
J. A. Lohmeyer ◽  
S. Liu ◽  
A. Condurache ◽  
S. Krüger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document